Sharps Technology

SKYA · NASDAQ

$2.83+$0.04 (+1.43%)TodayMarket closed ·
Prev close $2.79

About SKYA

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Employees
5
Headquarters
Melville, New York
Listed
Apr 14, 2022
Sector
Health Care
Industry
Health Care Equipment & Supplies

SKYA key statistics

Market cap
122.39M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.90M
Volume
2.71M
Open price
$2.80
High today
$2.84
Low today
$2.77
52 Week high
$5.49
52 Week low
$0.91

Sharps Technology (SKYA) at a glance

As of Oct 20, 2026, Sharps Technology (SKYA) shares are priced at $2.83, giving the company a market cap of 122.39M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.77 and $2.84. The current price is 2.2% above the day's low and 0.4% below its high.

Volume so far is 2.71M shares, in line with the average of 2.90M shares a day.

Over the past year Sharps Technology has ranged from $0.91 to $5.49, and now sits 42% of the way up that range.

Sharps Technology met or beat analyst EPS estimates in 0 of the last 4 quarters. In Q3 FY25 it reported -$4.33 per share against an estimate of -$1.03.

SKYA earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 4 quarters.

  1. Q2 FY23: reported -$1,452.00 per share against an estimate of -$538.56
  2. Q4 FY23: reported -$1,122.00 per share against an estimate of -$942.48
  3. Q1 FY24: reported -$330.00 per share against an estimate of -$269.28
  4. Q3 FY25: reported -$4.33 per share against an estimate of -$1.03

SKYA news

  • Lekha Gupta

    Why Is SkyAI Stock Surging Monday?

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

Similar companies

Companies in the same industry as Sharps Technology

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.